Status report
Get it in writing
The official USPTO status record for TAKSTA, serial 77858564, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
TAKSTASerial 77858564 · Principal Register
Dead · Refused
Owner: CEM-102 Pharmaceuticals, Inc.
Class 005 - Pharmaceuticals
Filed Oct 27, 2009
The record shows that the “TAKSTA” application is dead – it was abandoned on July 1 2013 because the owner never filed a Statement of Use after the Notice of Allowance, and the USPTO mailed an abandonment notice that same day. The owner listed is CEM‑102 Pharmaceuticals, Inc., a Delaware corporation, and the filing was for class 005 pharmaceuticals covering “Antibiotics.” Because the registration never matured, the record does not give the owner control over every use of the word “TAKSTA,” but it does indicate a concrete concern for any later use that also involves antibiotics or related pharmaceutical products. The prosecution history shows a series of extensions of time to file the required Statement of Use, all of which ultimately expired without a filing, leading to the abandonment. The supplied history contains no oppositions, cancellations or court actions, so no enforcement signals appear. I'd treat this as a modest risk if you plan to use a similar name for anything in the antibiotics space, but the concern fades for unrelated goods or services.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.